ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
ESCALON MEDICAL CORP
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026
- Market cap
- $2.72M
- P/E (TTM)
- 0.7
- Dividend yield
- –
ESCALON MEDICAL CORP revenue by segment
By business segment
By product or service
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $2.47M | $3.42M | $2.54M | $2.45M | $3.31M | $3.10M | $2.65M | $3.32M | $2.57M | $2.73M | $2.80M | $2.97M | 94.7% | -25.4% |
| Service [Member] | $136.97K | $176.02K | $138.44K | $124.61K | $159.37K | $117.78K | $130.06K | $148.71K | $128.11K | $134.84K | $144.95K | $161.88K | 5.3% | -14.1% |
By region
From the segment and revenue-disaggregation notes of Escalon Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.